Botanical species · safety record

Cymbopogon flexuosus

The EFSA Compendium of Botanicals holds 2 constituent measurements for Cymbopogon flexuosus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Cymbopogon flexuosus (Nees ex Steud.) W.Watson

2Constituent measurements

0Safety records

2Cited sources

47Licensed products (Canada)

Also recorded as

Cymbopogon flexuosus var. sikkimensis Bor

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 47 licensed products naming Cymbopogon flexuosus as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

Herb top
Leaf

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Methyleugenol	Aerial part of plants	Essential oil	≤ 82.4 Percent	Unspecified	No resolvable identifier
Methyleugenol	Unspecified	Essential oil	20 Percent	Unspecified	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Hazarika, J. N., Barua, A., Baruah, A. K. S. Cymbopogon flexuosus (Nees and Steud) Watts. var. Sikkimensis Bor - a rich source of methyleugenol. Indian drugs, 1977, p. 195-197.
Atal, C. K., Bradu, B. L. Search for aroma chemicals of industrial value from genus cymbopogon. Part IV. Chandi and Kolar grasses as source of methyleugenol. Indian journal of pharmacy, 1976, p. 63-64.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature